Cover art for Tempus AI: 3 Key Takeaways for Long-Term Investors

Tempus AI: 3 Key Takeaways for Long-Term Investors

Tempus AI's 2026 earnings show $193M data deals and $80M oncology pricing boost for long-term investors.

4 cards · 50s · tap to begin

From · · · 50s

Tempus AI: 3 Key Takeaways for Long-Term Investors

Tempus AI's 2026 earnings show $193M data deals and $80M oncology pricing boost for long-term investors.

In brief

Tempus AI's 2026 earnings show $193M data deals and $80M oncology pricing boost for long-term investors. Tempus AI's third-quarter 2026 earnings report $411.5M revenue up 23% YoY with $193M data licensing and $80M oncology ASP gains expected by 2027. Originally reported by The Motley Fool.

Q3 2026 Revenue

Tempus AI reported third-quarter 2026 revenue of $411.5 million, up 23% year over year.

Multiyear Biopharma Deals

Long-term licensing agreements with biopharma partners like Pathos AI generate $193 million in data revenue over five years.

“Through this collaboration, Pathos is paying Tempus $55 million over a 5-year term. As a result, over the next approximately 5 years, we expect to generate $193 million of additional data and applications revenue from these agreements alone.”

Oncology Pricing Boost

FDA-approved pricing changes will add $80 million in oncology average selling price gains by 2027.

“Given the expansion of our FDA approval to include tumor-only for XT test, that updated pricing will kick in on January 1 and allow us to move the remaining XT over. That gives us about $80 million of uplift in oncology ASP in 2027.”

Positive Adjusted EBITDA

Tempus achieved positive adjusted EBITDA of $25.6 million in Q3 2026 after gross profit growth outpaced investments.

The bottom line

Tempus AI's third-quarter 2026 earnings report $411.5M revenue up 23% YoY with $193M data licensing and $80M oncology ASP gains expected by 2027.

Read the original on The Motley Fool

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on tempus ai and related topics.